首页> 美国卫生研究院文献>other >Inhibition of non-homologous end joining increases the efficiency of CRISPR/Cas9-mediated precise TM: inserted genome editing
【2h】

Inhibition of non-homologous end joining increases the efficiency of CRISPR/Cas9-mediated precise TM: inserted genome editing

机译:抑制非同源末端连接可提高CRISPR / Cas9介导的精确TM:插入基因组编辑的效率

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Methods to introduce targeted double-strand breaks (DSBs) into DNA enable precise genome editing by increasing the rate at which externally supplied DNA fragments are incorporated into the genome through homologous recombination. The efficiency of these methods is limited by non-homologous end joining (NHEJ), an alternative DNA repair pathway that competes with homology-directed repair (HDR). To promote HDR at the expense of NHEJ, we targeted DNA ligase IV, a key enzyme in the NHEJ pathway, using the inhibitor Scr7. Scr7 treatment increased the efficiency of HDR-mediated genome editing using Cas9 in mammalian cell lines and in mice for all four genes examined up to 19-fold. This approach should be applicable to other customizable endonucleases, such as zinc finger nucleases and transcription activator like effector nucleases, and to non-mammalian cells with sufficiently conserved mechanisms of NHEJ and HDR.
机译:将靶向双链断裂(DSB)引入DNA的方法通过提高通过同源重组将外部提供的DNA片段掺入基因组的速率,可以进行精确的基因组编辑。这些方法的效率受到非同源末端连接(NHEJ)的限制,NHEJ是与同源定向修复(HDR)竞争的另一种DNA修复途径。为了以NHEJ为代价促进HDR,我们使用抑制剂Scr7靶向了DNA连接酶IV(NHEJ途径中的关键酶)。 Scr7处理提高了使用Cas9在哺乳动物细胞系和小鼠中对所有四个基因检查的19倍的HDR介导的基因组编辑的效率。此方法应适用于其他可定制的核酸内切酶,例如锌指核酸酶和转录激活子(如效应子核酸酶),以及具有NHEJ和HDR足够保守机制的非哺乳动物细胞。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号